Welcome to LookChem.com Sign In|Join Free

CAS

  • or

133562-32-0

Post Buying Request

133562-32-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133562-32-0 Usage

Derivative of

Phenylethanolamine

Functional Groups

Contains both an amino group and a hydroxyl group

Use in Pharmaceutical Industry

Building block in the synthesis of various drugs and pharmaceuticals

Use in Organic Synthesis

Reagent in organic synthesis
Intermediate in the production of other chemical compounds

Physical Properties

Appearance: White crystalline solid
Solubility: Sparingly soluble in water, soluble in organic solvents

Potential Applications

Medicine
Chemistry
Materials science

Check Digit Verification of cas no

The CAS Registry Mumber 133562-32-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,5,6 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 133562-32:
(8*1)+(7*3)+(6*3)+(5*5)+(4*6)+(3*2)+(2*3)+(1*2)=110
110 % 10 = 0
So 133562-32-0 is a valid CAS Registry Number.

133562-32-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Amino-1-(2,6-difluorophenyl)ethanol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:133562-32-0 SDS

133562-32-0Downstream Products

133562-32-0Relevant articles and documents

Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agents

Chennamaneni, Naveen Kumar,Arif, Jenifer,Buckner, Frederick S.,Gelb, Michael H.

supporting information; experimental part, p. 6582 - 6584 (2010/06/12)

We developed a synthetic route to prepare isoquinoline analogs of the cancer drug clinical candidate tipifarnib. We show that these compounds kill Trypanosoma cruzi amastigotes grown in mammalian host cells at concentrations in the low nanomolar range. Th

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 133562-32-0